BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9368619)

  • 1. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection.
    Seiler P; Aichele P; Odermatt B; Hengartner H; Zinkernagel RM; Schwendener RA
    Eur J Immunol; 1997 Oct; 27(10):2626-33. PubMed ID: 9368619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
    Bocharov GA
    J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.
    McFarland HI; Nahill SR; Maciaszek JW; Welsh RM
    J Immunol; 1992 Aug; 149(4):1326-33. PubMed ID: 1500720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
    Von Herrath MG; Coon B; Oldstone MB
    Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
    Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
    J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
    Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
    J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells.
    Battegay M; Kyburz D; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Dec; 23(12):3236-41. PubMed ID: 8258339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of tolerance to a chronic viral infection.
    Jamieson BD; Somasundaram T; Ahmed R
    J Immunol; 1991 Nov; 147(10):3521-9. PubMed ID: 1940352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.
    Ludewig B; Oehen S; Barchiesi F; Schwendener RA; Hengartner H; Zinkernagel RM
    J Immunol; 1999 Aug; 163(4):1839-44. PubMed ID: 10438917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect.
    Tishon A; Borrow P; Evans C; Oldstone MB
    Virology; 1993 Aug; 195(2):397-405. PubMed ID: 8393233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal intraepithelial lymphocytes respond to systemic lymphocytic choriomeningitis virus infection.
    Sydora BC; Jamieson BD; Ahmed R; Kronenberg M
    Cell Immunol; 1996 Feb; 167(2):161-9. PubMed ID: 8603424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.